Opiate tolerance to daily heroin administration:: An apparent phenomenon associated with enhanced pain sensitivity

被引:129
作者
Laulin, JP [1 ]
Célèrier, E [1 ]
Larcher, A [1 ]
Le Moal, M [1 ]
Simonnet, G [1 ]
机构
[1] INSERM U259, F-33077 Bordeaux, France
关键词
opiate tolerance; intermittent heroin administration; NMDA-receptor antagonist; analgesic effectiveness; pain sensitivity; rat;
D O I
10.1016/S0306-4522(98)00652-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
From a classical viewpoint, tolerance to analgesic effects of opiates refers to the decreased effectiveness of a given opiate following its repeated use.(11) Despite much research, it has not been conclusively demonstrated in vivo that functional changes observed at the opioid receptor level in the responsiveness to opiates account for development of tolerance.(2,9,10,36) An alternative hypothesis is that opioid receptors remain operative following repeated opiate administration but that opioid receptor activation rapidly induces a prolonged increase in pain sensitivity which opposes the predominant opiate analgesic effect following repeated opiate administration. We recently showed that a single heroin administration induces an enhanced pain sensitivity for several days,(27) a phenomenon which is prevented by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Herein we report that repeated once-daily heroin injections induced a gradual lowering of the nociceptive threshold which progressively masked a sustained heroin analgesic functional effect, MK-801 prevented such opiate-induced allodynia and thereby prevented development of an apparent decrease in the effectiveness of heroin. These results indicate that intermittent heroin administration induced a persistent increase in the basal pain sensitivity which, if not taken into account gives the impression of less analgesia, i.e. apparent tolerance. (C) 1999 IBRO. Published by Elsevier Science Ltd.
引用
收藏
页码:631 / 636
页数:6
相关论文
共 42 条
[1]   POTENTIATION OF MORPHINE-INDUCED ANTINOCICEPTION IN ACUTE SPINAL RATS BY THE NMDA ANTAGONIST DEXTRORPHAN [J].
ADVOKAT, C ;
RHEIN, FQ .
BRAIN RESEARCH, 1995, 699 (01) :157-160
[2]   INSIGHTS INTO THE DEVELOPMENT OF OPIOID TOLERANCE [J].
BASBAUM, AI .
PAIN, 1995, 61 (03) :349-352
[3]   THE NMDA RECEPTOR ANTAGONIST-MK-801 PREVENTS LONG-LASTING NONASSOCIATIVE MORPHINE-TOLERANCE IN THE RAT [J].
BENELIYAHU, S ;
MAREK, P ;
VACCARINO, AL ;
MOGIL, JS ;
STERNBERG, WF ;
LIEBESKIND, JC .
BRAIN RESEARCH, 1992, 575 (02) :304-308
[4]   DIZOCILPINE (MK-801) BLOCKS TOLERANCE TO THE ANALGESIC BUT NOT TO THE HYPERTHERMIC EFFECT OF MORPHINE IN THE RAT [J].
BHARGAVA, HN ;
MATWYSHYN, GA .
PHARMACOLOGY, 1993, 47 (06) :344-350
[5]  
BLASIG J, 1973, PSYCHOPHARMACOLOGIA, V33, P19
[6]   PROTEIN-KINASE-C REDUCES MG2+ BLOCK OF NMDA-RECEPTOR CHANNELS AS A MECHANISM OF MODULATION [J].
CHEN, L ;
HUANG, LYM .
NATURE, 1992, 356 (6369) :521-523
[7]   SUSTAINED POTENTIATION OF NMDA RECEPTOR MEDIATED GLUTAMATE RESPONSES THROUGH ACTIVATION OF PROTEIN-KINASE-C BY A MU-OPIOID [J].
CHEN, L ;
HUANG, LYM .
NEURON, 1991, 7 (02) :319-326
[8]   CONTRIBUTION OF CENTRAL NEUROPLASTICITY TO PATHOLOGICAL PAIN - REVIEW OF CLINICAL AND EXPERIMENTAL-EVIDENCE [J].
CODERRE, TJ ;
KATZ, J ;
VACCARINO, AL ;
MELZACK, R .
PAIN, 1993, 52 (03) :259-285
[9]   NEUROBIOLOGICAL MECHANISMS OF OPIOID TOLERANCE AND DEPENDENCE [J].
COLLIN, E ;
CESSELIN, F .
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (06) :465-488
[10]  
Colpaert FC, 1996, PHARMACOL REV, V48, P355